• Info
  • Insider Ownership

Insider Trading & Ownership of Matthew A. Spear

Location
San Diego, CA
Summary
The estimated net worth of Matthew A. Spear is at least $596,445 dollars as of 01 Mar 2022. Matthew A. Spear is the Chief Medical Officer of Poseida Therapeutics, Inc. and owns shares of Poseida Therapeutics, Inc. stock worth about $596.4K.
Signature
/s/ Harry J. Leonhardt, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Matthew A. Spear and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to save research and follow filings

Sponsored

Quick Takeaways

  • Matthew A. Spear has 1 issuer position tracked on this page.
  • Estimated disclosed ownership value: $596,445.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Poseida Therapeutics, Inc. ($596,445).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Matthew A. Spear

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
PSTX Poseida Therapeutics, Inc. Chief Medical Officer $596,445 01 Mar 2022

Insider Transactions Reported by Matthew A. Spear:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored